NCT05676931 2025-10-02
EDGE-Lung
Gilead Sciences
Phase 2 Active not recruiting
Clinical Trials
5 trialsNCT05910034 2023-06-18
Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLC
Fudan University
Phase 2 Not yet recruiting
NCT00983047 2015-08-27
Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 2 Terminated
NCT00783471 2010-06-16
DOPERLO
Hellenic Cooperative Oncology Group
Phase 2 Terminated
NCT00319514 2008-03-12
Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC
Gachon University Gil Medical Center
Phase 2 Completed